Last quarter (Q1 2024), Pharma Bio Services's total revenue was $2.38M, a decrease of -48.68% from the same quarter last year. In Q1, Pharma Bio Services's net income was $-270.72K. See Pharma Bio Services’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Oct 22	Oct 21	Oct 20	Oct 19	Oct 18
Total Revenue	$ 15.76M	$ 19.40M	$ 20.12M	$ 21.56M	$ 19.51M	$ 17.80M
Cost of Revenue	$ 11.09M	$ 14.52M	$ 14.76M	$ 14.90M	$ 13.33M	$ 12.11M
Gross Profit	$ 4.67M	$ 4.88M	$ 5.36M	$ 6.67M	$ 6.18M	$ 5.69M
Operating Expense	$ 6.97M	$ 3.71M	$ 9.21M	$ 4.44M	$ 4.48M	$ 4.60M
Operating Income	$ 730.88K	$ 1.17M	$ -3.85M	$ 2.23M	$ 1.70M	$ 1.09M
Net Non Operating Interest Income Expense	$ -134.62K	-	-	-	-	-
Other Income Expense	$ -746.67K	$ -13.42K	$ -1.98M	$ 64.46K	$ 526.57K	$ 435.53K
Pretax Income	$ 1.48M	$ 1.19M	$ -1.88M	$ 2.29M	$ 2.22M	$ 1.52M
Tax Provision	$ 390.94K	$ 181.68K	$ 213.25K	$ 239.09K	$ 135.99K	$ 2.79M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ 1.09M	$ 1.01M	$ -2.09M	$ 2.05M	$ 2.09M	$ 1.28M
Basic EPS	-	-	-	$ 0.09	$ 0.09	$ 0.06
Diluted EPS	-	-	-	$ 0.09	$ 0.09	$ 0.06
Basic Average Shares	$ 91.84M	$ 23.00M	$ 23.03M	$ 23.00M	$ 23.05M	$ 23.08M
Diluted Average Shares	$ 91.95M	$ 23.03M	$ 23.16M	$ 23.04M	$ 23.11M	$ 23.10M
Dividend Per Share	$ 0.08	-	-	$ 0.00	$ 0.07	$ 0.07
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 18.06M	$ -18.22M	$ 23.97M	$ 19.34M	$ 17.81M	$ 16.71M
Net Income From Continuing And Discontinued Operation	$ 1.09M	$ 1.01M	$ -2.09M	$ 2.05M	$ 2.09M	$ 1.28M
Normalized Income	$ 2.05M	-	-	$ 2.05M	$ 2.09M	$ -1.26M
Interest Expense	-	-	-	-	-	-
EBIT	$ 1.61M	$ 1.19M	$ -1.88M	$ 2.23M	$ 1.70M	$ 1.09M
EBITDA	$ 1.70M	$ 1.24M	$ -1.80M	$ 2.31M	$ 1.80M	$ 1.16M

Currency in USD

Pharma Bio Services Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing